Trending Stories on Eyewire+
FDA Approves Susvimo for Diabetic Macular Edema (DME)
The FDA?has approved Genentech's Susvimo ocular implant (ranibizumab) 100 mg/mL for the treatment of diabetic macular edema (DME). The approval makes Susvimo?the first and only FDA-approved treatment shown to maintain vision in people with DME with fewer treatments than standard-of-care eye injections. Read More
Bausch + Lomb: No Immediate Plans to Go Private
After exploring options to separate from Bausch Health, Bausch + Lomb announced Thursday it decided not to engage in a sale.
“Taking Bausch + Lomb private with a third-party buyer was one of several options being explored to complete a full separation from Bausch Health Companies Inc. After engagement with potential buyers, that process is complete, and will not result in a transaction at this time," B+L stated in news release. Read More
Lumenis Launches OptiLIFT, Device to Address Lower Lid Laxity and Impaired Blinking
Lumenis announced the launch of OptiLIFT, a new device that uses Dynamic Muscle Stimulation technology (DMSt) to tone facial muscles to improve lower lid laxity and impaired blinking. OptiLIFT marks one of the first treatment options that eliminates the need for surgery. Read More
EyewireTV | 2.05.2025
The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its?C.Rex micro-interventional system; and there are several executiveleadership announcements made in ophthalmology. Click here to check it out!
Latest In Podcasts
领英推荐
The Psychology of Refractive Surgical Patients
Neda Nikpoor , MD, and Neda Shamie, MD , are joined by Karl G. Stonecipher, MD, to explore strategies for improving the patient experience in refractive surgery. Dr. Stonecipher shares insights on addressing patient anxieties, building trust through personalized consultations, and creating a welcoming clinical environment. The discussion highlights the importance of understanding each patient’s unique concerns, using body language and open-ended questions to guide conversations, and fostering a supportive team culture. Click here to catch the latest episode.
Eyewire News: The Podcast
The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its?C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology. Learn more about your ad choices. Catch the latest episodes here!
Latest in Subspecialties:
GLAUCOMA: Qlaris Bio Announces Positive Topline Data From Two Phase 2 Trials of QLS-111 for Glaucoma
Thank you for reading! We'll be back next week with another edition of?Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.